After announcing another late-stage success, Karuna Therapeutics’ much-anticipat...
VistaGen Therapeutics has announced the successful completion of Phase 3 safety ...
Takeda has revealed the information that prompted them to buy the TYK2 inhibitor...
Late-stage trial data suggests Sanofi and Regeneron’s Dupixent is on its way to ...
Sanofi has announced that it will reduce the list price of its popular insulin m...
As the number of individuals in need of care is growing rapidly and there will p...
The U.S. Food and Drug Administration (FDA) has granted approval to Acadia Pharm...
The Life Sciences Industry is an ever-growing industry that is responsible for t...
The first over-the-counter, at-home test that can identify both COVID-19 and inf...
Olympus has made a $370M bid to acquire Taewoong Medical. An updated plan was h...
Moderna announced that U.S. authorities have approved its experimental personali...
This week we take a look at FDA’s approval for the first home test kit, how soci...
The FDA is considering granting de novo clearance for a device aimed at treating...
Patients suffering from peripheral arterial disease (PAD) frequently require low...
The Food and Drug Administration (FDA) has cleared Abbott’s laboratory blood tes...
“Maps don’t show you where you will go in life, they show you where you might go...
